The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow
Publication date
2009-11Keyword
Medicinal chemistryChemical biology
Diversity-oriented synthesis
EPSRC
Government funding
NCI
Cancer drug discovery
Peer-Reviewed
YesOpen Access status
closedAccess
Metadata
Show full item recordAbstract
Since the development of the first cytotoxic agents, synthetic organic chemistry has advanced enormously. The synthetic and medicinal chemists of today are at the centre of drug development and are involved in most, if not all, processes of drug discovery. Recent decreases in government funding and reformed educational policies could, however, seriously impact on drug discovery initiatives worldwide. Not only could these changes result in fewer scientific breakthroughs, but they could also negatively affect the training of our next generation of medicinal chemists.Version
No full-text in the repositoryCitation
Pors K, Goldberg FW, Leamon CP et al (2009) The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow. Drug Discovery Today. 14 (21/22): 1045-50.Link to Version of Record
https://doi.org/10.1016/j.drudis.2009.07.004Type
Articleae974a485f413a2113503eed53cd6c53
https://doi.org/10.1016/j.drudis.2009.07.004